FDA to authorize Novavax's Covid-19 vaccine - POLITICO - POLITICO

Quick Read

Still, the Novavax vaccine offers a fourth option at a time when White House officials are stressing vaccinations and boosters as key to preventing severe infection that could lead to hospitalization or death, even as the BA.
In June, the FDA’s external advisory committee of experts voted 21-to-0 with one abstention to recommend the agency authorize the Novavax vaccine.
Novavax’s vaccine uses an older technology than other Covid-19 vaccines: a recombinant protein made with moth cells.
5 rise across the country, we encourage all Americans to get vaccinated if they haven’t already,” Ashish Jha, the White House Covid response coordinator, said in a press briefing on Tuesday.
and Mexico, the vaccine was more than 90 percent effective at preventing Covid-19 infections and 100 percent effective at preventing hospitalizations.

FDA to authorize Novavax's Covid-19 vaccine - POLITICO - POLITICO

The FDA declined to comment, and the people with knowledge of the matter cautioned the plan could still change. Novavax, a biotech company headquartered in Maryland, still needs to complete a final round of quality testing for its vaccine over the next several days. But the Biden administration earlier this week purchased 3.2 million doses of the vaccine in anticipation of the shot soon receiving a green light from the agency. The expected authorization comes after two years of setbacks for Novavax, once considered among the most promising Covid vaccine developers. The Trump administration in 2020 went as far as pre-ordering 110 million doses of the vaccine, investing $1.6 billion in the process. But the company, which had never produced a successful vaccine before, ran into a series of production issues and struggled for months to meet U.S. regulatory standards, falling well behind the pace set by competitors. Meanwhile, the FDA authorized vaccines from Moderna, Pfizer-BioNTech and Johnson & Johnson, and hundreds of millions of shots were rolled out for the Biden administration’s vaccination campaign. The agency has since cleared Covid vaccines for everyone six months and up, as well as several rounds of booster shots, and granted full approval to Pfizer’s vaccine for children as young as 12. As Novavax prepares to launch its initial shots in the U.S., the other vaccine manufacturers are working with administration officials to settle on reformulated vaccine boosters that better target the mutating virus and are expected to be distributed later this fall. Still, the Novavax vaccine offers a fourth option at a time when White House officials are stressing vaccinations and boosters as key to preventing severe infection that could lead to hospitalization or death, even as the BA.4 and BA.5 subvariants of the Omicron strain dominate infections across the country. “As we see BA.5 rise across the country, we encourage all Americans to get vaccinated if they haven’t already,” Ashish Jha, the White House Covid response coordinator, said in a press briefing on Tuesday. In June, the FDA’s external advisory committee of experts voted 21-to-0 with one abstention to recommend the agency authorize the Novavax vaccine. In late-stage clinical trials with more than 25,000 participants spanning the U.S. and Mexico, the vaccine was more than 90 percent effective at preventing Covid-19 infections and 100 percent effective at preventing hospitalizations. Novavax’s vaccine uses an older technology than other Covid-19 vaccines: a recombinant protein made with moth cells. The company’s trials were conducted when the Alpha variant of the coronavirus was the predominant strain. While the company has provided the FDA with updated data, including the vaccine’s effectiveness against the Omicron variant, those data weren’t available for the external advisers at the time of their vote. Once the FDA officially authorizes the Novavax shot, it will still need an endorsement from the Centers for Disease Control and Prevention, which typically happens quickly.
The Original Article can be found on POLITICO

Minnesota fall 2022 COVID hospitalization and death predictions

The Centers for Disease Control and Prevention’s new COVID-19 Forecast Hub shows hospitalization and death predictions for Minnesota heading into the fall. The CDC’s forecast comp …

Read more here
Minnesota fall 2022 COVID hospitalization and death predictions

What long COVID looks like in kids

(NEXSTAR) – While it’s not clear exactly how many children suffer from long COVID, doctors who work with children are seeing some of them continue to struggle weeks or months after …

Read more here
What long COVID looks like in kids

COVID-19 boosters for Omicron variant available locally, in select locations

COVID-19 boosters targeting the BA.4 and BA.5 strains are now available across the Central Coast, but supply is limited. If you try to schedule a COVID-19 booster with CVS for exa …

Read more here
COVID-19 boosters for Omicron variant available locally, in select locations

News Scan for Sep 07, 2022

Vaccinated medical conference attendees had low rates of COVID-19 Today JAMA Network Open published a study showing a 1.8% COVID-19 infection rate among in-person attendees at a F …

Read more here
News Scan for Sep 07, 2022

Board debates business incentives, COVID

The late Betty Lynn was known to millions of “The Andy Griffith Show” fans as the long-suffering, sweet-hearted girlfriend of Deputy Barney Fife. Over the decades since the show l …

Read more here
Board debates business incentives, COVID